Vascular Endothelial Growth Factor and Thrombopoietin in Patients with Essential Thrombocythemia and Polycythemia vera and Thrombotic Complications

Publisher： Karger

E-ISSN： 1421-9662|110|4|202-203

ISSN： 0001-5792

Source： Acta Haematologica, Vol.110, Iss.4, 2003-12, pp. : 202-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Elevated Levels of Serum Vascular Endothelial Growth Factor in Patients with Polycythaemia vera

By  

Acta Haematologica, Vol. 110, Iss. 1, 2003-09 ,pp. : 16-19

Karger

Access to resources Recommend Favorite

Perspectives on the increased risk of second cancer in patients with essential thrombocythemia, polycythemia vera and myelofibrosis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 96-98

John Wiley & Sons Inc

Access to resources Recommend Favorite

Initial (Latent) Polycythemia vera with Thrombocytosis Mimicking Essential Thrombocythemia

By  

Acta Haematologica, Vol. 113, Iss. 4, 2005-06 ,pp. : 213-219

Karger

Access to resources Recommend Favorite

Target hematologic values in the management of essential thrombocythemia and polycythemia vera

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 1, 2015-01 ,pp. : 4-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk‐stratification and management

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 162-173

John Wiley & Sons Inc

Access to resources Recommend Favorite